Clinical Trial Update: Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating arnica tincture for the treatment of cutaneous leishmaniasis is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Leishmaniasis

Drugs mentioned

• Arnica tincture (arnica tincture)

Snippet

Sponsor: Universidad de Antioquia | Conditions: Leishmaniasis, Cutaneous | Phase 1 | Status: ACTIVE_NOT_RECRUITING